Combination of subtotal pneumofibrosis and post-COVID pulmonary complications in the context of the progression of systemic sclerosis (clinical observation)
M. V. Mnikhovich,
A. A. Soldatova,
I. A. Shiripenko,
O. А. Sidorova,
M. V. Lozina,
S. V. Snegur,
Yu. G. Pavlova,
P. P. Baklanov,
D. D. Kaminer https://doi.org/10.14412/1996-7012-2024-6-85-89
Abstract
We present a clinical case of the development of subtotal pneumofibrosis associated with the progression of systemic sclerosis in a patient previously infected with COVID-19. Investigating the possible relationship between these conditions is important both for understanding the current therapeutic algorithm and for further aetiopathogenetic studies on the nature of rheumatic diseases.
Supporting agencies: The investigation has not been sponsored.
About the Authors
M. V. Mnikhovich
Avtsyn Research Institute of Human Morphology of Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
3, Tsyrupy Street, Moscow 117418
A. A. Soldatova
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Antonina Alekseevna Soldatova
1, Ostrovityanova Street, Moscow 117513
I. A. Shiripenko
Avtsyn Research Institute of Human Morphology of Petrovsky National Research Center of Surgery; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
3, Tsyrupy Street, Moscow 117418; 1, Ostrovityanova Street, Moscow 117513
O. А. Sidorova
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
3A, Internatsionalnaya Street, Ryazan 390039
M. V. Lozina
Avtsyn Research Institute of Human Morphology of Petrovsky National Research Center of Surgery; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
3, Tsyrupy Street, Moscow 117418; 1, Ostrovityanova Street, Moscow 117513
S. V. Snegur
Ryazan Regional Clinical Hospital
Russian Federation
Russian Federation
3A, Internatsionalnaya Street, Ryazan 390039
Yu. G. Pavlova
Ryazan Regional Clinical Hospital
Russian Federation
Russian Federation
3A, Internatsionalnaya Street, Ryazan 390039
P. P. Baklanov
Ryazan Regional Clinical Hospital
Russian Federation
Russian Federation
3A, Internatsionalnaya Street, Ryazan 390039
D. D. Kaminer
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
1, Ostrovityanova Street, Moscow 117513
References
1. Chinova AA, Zatsepina MN, Ponomareva LA, et al. Interstitial lung disease associated with systemic sclerosis in a patient with longterm employment as a marble worker. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2022;16(4):63–68. (In Russ.). doi: 10.14412/1996-7012-2022-4-63-68.
2. Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res. 2019 Jan 18;20(1):13. doi: 10.1186/s12931-019-0980-7.
3. Ananyeva LP, Tyurin IE, Koneva OA, et al. Interstitial lung disease in systemic sclerosis (systemic scleroderma). Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2021;15(Suppl. 1):1-62. (In Russ.). doi: 10.14412/1996-7012-2021-1S-1-62.
4. Voytsekhovskiy VV, Goborov ND, Pogrebnaya MV, et al. Lung damage in systemic scleroderma. Byulleten' fiziologii i patologii dykhaniya. 2018;(70):83-92. (In Russ.).
5. Swarnakar R, Garje Y, Markandeywar N, Mehta S. Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis. Lung India. 2022 MayJun;39(3):279-285. doi: 10.4103/lungindia.lungindia_89_22.
6. Denton CP, Campochiaro C, Bruni C, et al. COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic. J Scleroderma Relat Disord. 2021 Feb;6(1):58-65. doi:10.1177/2397198320963393
7. Aram K, Patil A, Goldust M, et al. COVID-19 and exacerbation of dermatological diseases: A review of the available literature. Dermatol Ther. 2021 Nov;34(6):e15113. doi:10.1111/dth.15113
8. Ferri C, Giuggioli D, Raimondo V, et al. COVID-19 & ASD Italian Study Group. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020 Nov;39(11): 3195-3204. doi: 10.1007/s10067-020-05334-7.
9. Gianfrancesco MA, Hyrich KL, Gossec L, et al. COVID-19 Global Rheumatology Alliance Steering Committee. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. 2020 May;2(5):e250-e253. doi: 10.1016/S2665-9913(20)30095-3.
Review
For citations:
Mnikhovich MV, Soldatova AA, Shiripenko IA, Sidorova OА, Lozina MV, Snegur SV, Pavlova YG, Baklanov PP, Kaminer DD. Combination of subtotal pneumofibrosis and post-COVID pulmonary complications in the context of the progression of systemic sclerosis (clinical observation). Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2024;18(6):85-89. (In Russ.) https://doi.org/10.14412/1996-7012-2024-6-85-89
Views:
795
Email this article 